These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22781546)

  • 1. Oxidative stress in stable cystic fibrosis patients: do we need higher antioxidant plasma levels?
    Lezo A; Biasi F; Massarenti P; Calabrese R; Poli G; Santini B; Bignamini E
    J Cyst Fibros; 2013 Jan; 12(1):35-41. PubMed ID: 22781546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Markers of oxidative damage in blood of children with cystic fibrosis].
    Chełchowska M; Laskowska-Klita T; Nowaczewska I; Narolewska U
    Pol Merkur Lekarski; 2002 Aug; 13(74):123-5. PubMed ID: 12420342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for increased oxidative damage in patients with cystic fibrosis.
    Brown RK; Kelly FJ
    Pediatr Res; 1994 Oct; 36(4):487-93. PubMed ID: 7816524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
    Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional supplement attenuates selected oxidative stress markers in pediatric patients with cystic fibrosis.
    Sadowska-Woda I; Rachel M; Pazdan J; Bieszczad-Bedrejczuk E; Pawliszak K
    Nutr Res; 2011 Jul; 31(7):509-18. PubMed ID: 21840467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentration of plasma beta-carotene in cystic fibrosis children with pancreatic insufficiency].
    Laskowska-Klita T; Chełchowska M
    Med Wieku Rozwoj; 2002; 6(3):267-72. PubMed ID: 12637781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced oxidative damage in cystic fibrosis patients.
    Domínguez C; Gartner S; Liñán S; Cobos N; Moreno A
    Biofactors; 1998; 8(1-2):149-53. PubMed ID: 9699024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in cystic fibrosis: dietary and metabolic factors.
    Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Collins CE; Garg ML
    J Am Coll Nutr; 2001 Apr; 20(2 Suppl):157-65. PubMed ID: 11349939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline supplementation alters some amino acid concentrations with no change in homocysteine in children with cystic fibrosis and pancreatic insufficiency.
    Alshaikh B; Schall JI; Maqbool A; Mascarenhas M; Bennett MJ; Stallings VA
    Nutr Res; 2016 May; 36(5):418-29. PubMed ID: 27101760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde.
    McGrath LT; McGleenon BM; Brennan S; McColl D; McILroy S; Passmore AP
    QJM; 2001 Sep; 94(9):485-90. PubMed ID: 11528012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
    Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
    Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous GC-MS/MS measurement of malondialdehyde and 4-hydroxy-2-nonenal in human plasma: Effects of long-term L-arginine administration.
    Tsikas D; Rothmann S; Schneider JY; Gutzki FM; Beckmann B; Frölich JC
    Anal Biochem; 2017 May; 524():31-44. PubMed ID: 27530652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial.
    Scambi C; De Franceschi L; Guarini P; Poli F; Siciliano A; Pattini P; Biondani A; La Verde V; Bortolami O; Turrini F; Carta F; D'Orazio C; Assael BM; Faccini G; Bambara LM
    PLoS One; 2009; 4(3):e4782. PubMed ID: 19277125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
    Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
    Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
    Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation in diabetic retinopathy.
    Polak M; Zagórski Z
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):434-7. PubMed ID: 16146026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients.
    Shmarina GV; Pukhalsky AL; Kokarovtseva SN; Pukhalskaya DA; Kalashnikova EA; Kapranov NI; Kashirskaja NJ
    Mediators Inflamm; 2001 Apr; 10(2):61-7. PubMed ID: 11405551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.